Latest Anew Labs news, funding rounds and robotics & AI coverage. $290M raised. 2 articles tracked by The Robotics Media.
Anew Labs is a Shanghai-based AI drug discovery company spun off from ByteDance's internal AI-for-biology unit. It uses foundation models to design small molecules and biologics and to compress drug-development timelines.
On September 16, 2026 Anew Labs closed a $290 million inaugural external round from HSG, IDG Capital, Hillhouse Investment and 5Y Capital at a reported $1.5 billion valuation, with ByteDance retaining a 56% stake.